Chongqing Zhifei Biological Products Company Overview
- Year Founded
-
2001
- Status
-
Public
- Employees
-
6,292
- Stock Symbol
-
300122
- Investments
-
8
- Share Price
-
$2.08
- (As of Friday Closing)
Chongqing Zhifei Biological Products Company General Information
Description
Chongqing Zhifei Biological Products Co Ltd is engaged in research and development, production, and sales of vaccines and biological products. The company's main products include bacterial vaccines for the prevention of meningitis and pneumonia-based bacteria, biological products for the prevention and treatment of tuberculosis, viral vaccines for the prevention of rabies virus, influenza virus, and other viruses, general drugs and other biological products, among others.
Contact Information
Website
www.zhifeishengwu.comCorporate Office
- No. 7, Jinyuan Road
- 25th Floor, Jiangbei District
- Chongqing, 400020
- China
Corporate Office
- No. 7, Jinyuan Road
- 25th Floor, Jiangbei District
- Chongqing, 400020
- China
Chongqing Zhifei Biological Products Company Stock Performance
As of 13-Nov-2026, Chongqing Zhifei Biological Products Company’s stock price is $2.08. Its current market cap is $4.97B with 2.39B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.08 | $2.08 | $1.63 - $3.09 | $4.97B | 2.39B | 37.4M | -$0.85 |
Chongqing Zhifei Biological Products Company Financials Summary
As of 30-Sep-2026, Chongqing Zhifei Biological Products Company has a trailing 12-month revenue of $1.14B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 6,235,752 | 6,456,017 | 8,820,683 | 20,832,634 |
| Revenue | 1,139,286 | 1,245,729 | 3,630,322 | 7,486,108 |
| EBITDA | (2,378,812) | (2,318,209) | 367,642 | 1,374,388 |
| Net Income | (2,042,528) | (2,047,351) | 274,895 | 1,145,993 |
| Total Assets | 4,047,289 | 4,533,525 | 7,026,904 | 7,093,029 |
| Total Debt | 1,289,747 | 1,756,136 | 1,816,062 | 428,221 |
Chongqing Zhifei Biological Products Company Patents
Chongqing Zhifei Biological Products Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025157158-A1 | Pneumococcal conjugate combined vaccine and preparation method therefor | Pending | 24-Jan-2024 |
Chongqing Zhifei Biological Products Company Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Chongqing Zhifei Biological Products Company Investments & Acquisitions (8)
Chongqing Zhifei Biological Products Company’s most recent deal was a Merger/Acquisition with Chenan Biopharm for . The deal was made on 21-Mar-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Chenan Biopharm | 21-Mar-2025 | Merger/Acquisition | Drug Discovery | ||
| Inhal Pharma | 12-Mar-2025 | Early Stage VC | Other Pharmaceuticals and Biotechnology | ||
| XPrecise | 30-Jan-2024 | Early Stage VC | Monitoring Equipment | ||
| GenAns Biotech | 27-Dec-2022 | Seed Round | Drug Discovery | ||
| GuanQiao | 06-May-2022 | Early Stage VC | Therapeutic Devices |
Chongqing Zhifei Biological Products Company ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
30.65 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Biotechnology
Subindustry
of 431
Rank
Percentile
Chongqing Zhifei Biological Products Company Exits (3)
Chongqing Zhifei Biological Products Company’s most recent exit was on 24-Oct-2021 from KYinno Biotechnology. The exit was categorized as with 6 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| KYinno Biotechnology | 24-Oct-2021 | Completed |
|
||
| Innorna | 01-Mar-2021 | Completed |
|
||
| Innorna | 22-Oct-2020 | Seed Round | Completed |
|
Chongqing Zhifei Biological Products Company Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Chenan Biopharm | Chongqing, China | 2015 | |
| Zhifei Biological Investment | Chongqing, China |
Chongqing Zhifei Biological Products Company FAQs
-
When was Chongqing Zhifei Biological Products Company founded?
Chongqing Zhifei Biological Products Company was founded in 2001.
-
Where is Chongqing Zhifei Biological Products Company headquartered?
Chongqing Zhifei Biological Products Company is headquartered in Chongqing, China.
-
What is the size of Chongqing Zhifei Biological Products Company?
Chongqing Zhifei Biological Products Company has 6,292 total employees.
-
What industry is Chongqing Zhifei Biological Products Company in?
Chongqing Zhifei Biological Products Company’s primary industry is Drug Discovery.
-
Is Chongqing Zhifei Biological Products Company a private or public company?
Chongqing Zhifei Biological Products Company is a Public company.
-
What is Chongqing Zhifei Biological Products Company’s stock symbol?
The ticker symbol for Chongqing Zhifei Biological Products Company is 300122.
-
What is the current stock price of Chongqing Zhifei Biological Products Company?
As of 13-Nov-2026 the stock price of Chongqing Zhifei Biological Products Company is $2.08.
-
What is the current market cap of Chongqing Zhifei Biological Products Company?
The current market capitalization of Chongqing Zhifei Biological Products Company is $4.97B.
-
What is Chongqing Zhifei Biological Products Company’s current revenue?
The trailing twelve month revenue for Chongqing Zhifei Biological Products Company is $1.14B.
-
What is Chongqing Zhifei Biological Products Company’s annual earnings per share (EPS)?
Chongqing Zhifei Biological Products Company’s EPS for 12 months was -$0.85.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
